{"name":"Patrys Ltd.","slug":"patrys-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOTEFkVFhFM0tSSW5iaEtJU19QS09pdVdxRjhNaklzcFJfS0FDRzljOEczRlUzb2VWOXVxcnpTazlCRGVmUHdFYm1hclhIWlZTbFJvRmo0ampHREZtR09TSWtCSUdwcmdPb0lNUzcyZlh1VmhRQjdtUlhCVzZVeDVZNGtGNzRpTnpDeE92YU40dEhWaERqWVY5eUJCbUhiY2lubmVoeXE0WnJfR19tTHZrRFRoVQ?oc=5","date":"2026-03-17","type":"pipeline","source":"BioPharma APAC","summary":"BioCina Advances RLS 2201 With CMC Programme To Enable Clinical Entry - BioPharma APAC","headline":"BioCina Advances RLS 2201 With CMC Programme To Enable Clinical Entry","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-17","type":"pipeline","source":"The Manila Times","summary":"BioCina Initiates Comprehensive Manufacturing Program for Patrys' Proprietary Injectable Therapeutic to Alleviate Delirium - The Manila Times","headline":"BioCina Initiates Comprehensive Manufacturing Program for Patrys' Proprietary Injectable Therapeutic to Alleviate Deliri","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOcUFVQzZXQ001bEhHUlVwb0FDUVdzT0F6bUNhWV9RSnk2RGkzRTNMbm1xRUV0dzNmN3FvcmVOOG5CWldnWlh4UGY2elFMTHNBQ3FwZEs3bkFjSThQTTFhUjNxcHkzWWtZOGRoRUtmdXB0OHU5LUc5Z2Y1emZLQkdBRnRzSUVERjFOSFR5RXhHZHp5U05NckFlY1hiVVd3S3JqeEpZM3pPWU03dF96dTBxRGlPZ3VDX2ttNkdqaXVIZjlrN0l1ZE9PRUtn?oc=5","date":"2025-11-26","type":"trial","source":"businessnews.com.au","summary":"Patrys makes bold clinical-stage move with acquisition of WA private company Reliis, adding high-value delirium asset to ignite next phase of growth - businessnews.com.au","headline":"Patrys makes bold clinical-stage move with acquisition of WA private company Reliis, adding high-value delirium asset to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE1sWGdoM19BNXFpR0h3eloyUnFTRlJFcENsMFJFMlo3ZVA4NmF6RzVEeW1kX203MjFqRk9Tcnk5M1NDU3RaLTRkLUtOZ3o1R0Z4?oc=5","date":"2025-10-30","type":"pipeline","source":"smallcaps.com.au","summary":"Insights: Patrys Ltd (ASX:PAB) - smallcaps.com.au","headline":"Insights: Patrys Ltd (ASX:PAB)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOeVN2S1VRc01mN3daNzdyVjhKWUY2ZDFTaEhjUk42Nzg4TWd1MVNFM0oyN2k4TmZ6Y1VWU2RsUmRfenBoM1RsU2ZJVTFreFhnMTlNWi1ub3lLalVHWDVqY2pibkU3U3dKZl9YbW8tcE80dGZEd1Nfb2RXMHhFOTMweTZsNXVnemwzbkJFM19ORlF1MkJTYVZfY2ZyLThYR1VSbWhsTk14OXF6X28?oc=5","date":"2024-10-02","type":"pipeline","source":"Stockhead","summary":"Health Check: Farewell, adieu as Argent Biopharma holders back ASX delisting - Stockhead","headline":"Health Check: Farewell, adieu as Argent Biopharma holders back ASX delisting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQRlExVUg2VXFybzVRdUwtbGFPR0hjSEpiS2hvejB1SjM4Ym1BdXFxZWRhY1gzNFpsaWM2UTlqNThlSkRLUHJzZ3NFNnZQTVM3VEpqUlZOT0p6bEpWenRZMHNXSVJVOXhsYm5EdTR4aVFSSjl2QVNUdHVMaVpGSFBfZHJxVUdsR0JTRFdKOXRZajFXWVYzZmV6MnBqRVI3UTZEZVM3S24wNFRNOUYxSVdzNEtkMEptclpuN0VrWWVHVjBSRDU4VXktS1BWNEFDZ1dldXhtUXFQMGRFUQ?oc=5","date":"2023-11-08","type":"pipeline","source":"Proactive Investors","summary":"Patrys bolsters finances through $2.7 million R&D Tax Incentive rebate - Proactive Investors","headline":"Patrys bolsters finances through $2.7 million R&D Tax Incentive rebate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNeFk5RjgyMV9JQjc0VV9heVZLN1FJVm5jellvc3V5S0xvUWlnYkVORkZQNVJtbWdKRTc0THdta2R3UjJsVE83RkgtZG1TOWphUXMtQzVUTDNsdkxIMldyNnNfZDM3azRLT0w3M25lcVlHN24zS0hCNUFDMU5iMVNXSjFWNzlzM3FwMjJOWkN4dUlrZXRzWjNpQnV3WXZjUEdiQWlpMFN0NTJQWlJtVzRvY212U3JKZk5EQTdaZ2h3cThSbER0QUVoWjNybDVaLWxVOWtpdGZjaXZ2YVRCMHc?oc=5","date":"2022-02-27","type":"pipeline","source":"Proactive financial news","summary":"Patrys establishes stable cell line to produce PAT-DX3 anti-cancer candidate - Proactive financial news","headline":"Patrys establishes stable cell line to produce PAT-DX3 anti-cancer candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOeHgtYzBnQWJ3bWRGNGVWVWhwYmtjMUNDVXdUbnhEREIyaGtLZVpCRmU1S0wxRERad0dHbDB0SkhCTGxTbGsxdk9BeUJESEFvRW1TTVRIcUhFblZZcEE3aGQzMkx2bGxYWDlaaTg3YjdscUZiWGhQM3ZtTS1DeWQ3WGtsTkJNZzd2ZUwtNGM1WVlBWHZvYlo0cjRPR280TDZ6Zm1yM0FldmIyYkcwR3BkdVBqT1MwMXlBRHVBNkw0eUM4WjlRUDZjaEtyYWxSejRfNmNPTQ?oc=5","date":"2021-06-16","type":"trial","source":"businesswire.com","summary":"Patrys Limited Announces Publication of PAT-DX1 Preclinical Data in JCI - Insight - businesswire.com","headline":"Patrys Limited Announces Publication of PAT-DX1 Preclinical Data in JCI - Insight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE1tUlhmQVRkNzBXY2l5ZDZEMWlEVktrdm03UHhwU2ZpbFdyYUl6czFaOG51aV9Pd0pobW44bEVmNU5WTndlbkMyNERSTUF3YnhIRU40QmxJdw?oc=5","date":"2017-07-31","type":"pipeline","source":"TradingView","summary":"PAB Stock Price and Chart — ASX:PAB - TradingView","headline":"PAB Stock Price and Chart — ASX:PAB","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQTEdpZHNFa3RtS3kxVlNfMi1WMlB6WmJrbzlIcUZBLVdaSzV0U1VfN3dlbGpCNXZpMnNyMk1rWlJQb0JSckMwN1V1NXNnNjJIc0txbXlFY25WamZoM3VrOXpKOExWOF9pSWJFaWJpUzFua2tCU0dJMTlwbkVtbkJBWm5qVDljc0E2cW04NU0teS1YRmcyUTF4UzBQbXQ?oc=5","date":"2011-06-06","type":"pipeline","source":"Contract Pharma","summary":"Laureate Begins Production of Second Patrys Antibody - Contract Pharma","headline":"Laureate Begins Production of Second Patrys Antibody","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}